HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Madeleine A Kane Selected Research

Therapeutics

1/2020An International Phase 2 Study of Pazopanib in Progressive and Metastatic Thyroglobulin Antibody Negative Radioactive Iodine Refractory Differentiated Thyroid Cancer.
3/2010Approach to the thyroid cancer patient with extracervical metastases.
10/2008Axitinib is an active treatment for all histologic subtypes of advanced thyroid cancer: results from a phase II study.
12/2004Immune reconstitution inflammatory syndrome associated with Kaposi sarcoma during potent antiretroviral therapy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Madeleine A Kane Research Topics

Disease

4Thyroid Neoplasms (Thyroid Cancer)
01/2020 - 10/2008
4Neoplasms (Cancer)
01/2020 - 01/2005
2Disease Progression
01/2019 - 03/2010
2Squamous Cell Carcinoma (Epidermoid Carcinoma)
04/2006 - 01/2005
2Small Cell Lung Carcinoma (Small Cell Lung Cancer)
01/2004 - 06/2002
1Hypokalemia
01/2019
1B-Cell Lymphoma (Lymphoma, B Cell)
01/2019
1Adrenocortical Carcinoma
01/2019
1Neutropenia
04/2016
1Pancreatic Neoplasms (Pancreatic Cancer)
04/2016
1Neoplasm Metastasis (Metastasis)
03/2010
1Hypertension (High Blood Pressure)
10/2008
1Head and Neck Neoplasms (Head and Neck Cancer)
04/2007
1Mucositis
04/2007
1Squamous Cell Carcinoma of Head and Neck
12/2005
1Lung Neoplasms (Lung Cancer)
12/2005
1Immune Reconstitution Inflammatory Syndrome
12/2004
1Kaposi Sarcoma (Kaposi's Sarcoma)
12/2004
1Inflammation (Inflammations)
12/2004
1Renal Cell Carcinoma (Grawitz Tumor)
08/2003
1Transfusion-Related Acute Lung Injury
08/2003

Drug/Important Bio-Agent (IBA)

2IodineIBA
01/2020 - 10/2008
2Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA
04/2016 - 10/2008
2Axitinib (AG 013736)IBA
01/2014 - 10/2008
2Gastrin-Releasing PeptideIBA
01/2004 - 06/2002
1pazopanibFDA Link
01/2020
1ThyroglobulinFDA Link
01/2020
1Proteins (Proteins, Gene)FDA Link
01/2019
1gossypol acetic acidIBA
01/2019
1GossypolIBA
01/2019
1TroponinIBA
01/2019
1Capecitabine (Xeloda)FDA Link
04/2016
1Tyrosine Kinase InhibitorsIBA
04/2016
1GemcitabineFDA Link
04/2016
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
04/2016
1Epidermal Growth Factor (EGF)IBA
04/2016
1vandetanib (ZD6474)IBA
04/2016
1Iodine-131IBA
01/2014
1Thyroxine (Levothyroxine)FDA LinkGeneric
03/2010
1Sorafenib (BAY 43-9006)FDA Link
03/2010
1Sunitinib (Sutent)FDA Link
03/2010
1Docetaxel (Taxotere)FDA Link
04/2007
1ErythropoietinFDA Link
04/2007
1Gefitinib (Iressa)FDA Link
12/2005
1Folic Acid (Vitamin M)FDA LinkGeneric
01/2005
1Paclitaxel (Taxol)FDA LinkGeneric
12/2004
1GlucocorticoidsIBA
01/2004
1Dexamethasone (Maxidex)FDA LinkGeneric
01/2004
1Interleukin-2 (IL2)IBA
08/2003
1OligodeoxyribonucleotidesIBA
06/2002
1Messenger RNA (mRNA)IBA
06/2002
1Bombesin Receptors (Bombesin Receptor)IBA
06/2002

Therapy/Procedure

4Therapeutics
01/2020 - 12/2004
2Chemoprevention
04/2006 - 01/2005
1Salvage Therapy
01/2020
1Radiotherapy
04/2007
1Drug Therapy (Chemotherapy)
12/2004
1Platelet Transfusion (Blood Platelet Transfusions)
08/2003
1Immunotherapy
08/2003